Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
MAGEA6 Biologics Sequence Review Report 2026: Melanoma-associated antigen 6 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of MAGEA6 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MAGEA4 Biologics Sequence Review Report 2026: Melanoma-associated antigen 4 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of MAGEA4 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MAGEA3 Biologics Sequence Review Report 2026: Melanoma-associated antigen 3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of MAGEA3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MAGEA2 Biologics Sequence Review Report 2026: Melanoma-associated antigen 2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of MAGEA2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MAGEA12 Biologics Sequence Review Report 2026: Melanoma-associated antigen 12 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of MAGEA12 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MAGEA11 Biologics Sequence Review Report 2026: Melanoma-associated antigen 11 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of MAGEA11 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MAGEA1 Biologics Sequence Review Report 2026: Melanoma-associated antigen 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of MAGEA1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LY96 Biologics Sequence Review Report 2026: Lymphocyte antigen 96 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of LY96 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LY75 Biologics Sequence Review Report 2026: Lymphocyte antigen 75 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of LY75 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LY6G6F Biologics Sequence Review Report 2026: Lymphocyte antigen 6 complex locus protein G6f Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of LY6G6F sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LY6G5C Biologics Sequence Review Report 2026: Lymphocyte antigen 6 complex locus protein G5c Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of LY6G5C sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LY6D Biologics Sequence Review Report 2026: Lymphocyte antigen 6D Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of LY6D sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
5
6
7
8
9
>>
1245
>